BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220404T140000
DTEND;TZID=Europe/Stockholm:20220404T150000
DTSTAMP:20260404T003732
CREATED:20220325T125600Z
LAST-MODIFIED:20220325T143719Z
UID:64273-1649080800-1649084400@www.scilifelab.se
SUMMARY:Information Meeting: Call for therapeutic oligonucleotide projects
DESCRIPTION:This digital information meeting will be held April 4\, 2022 at 14.00–15.00. At this meeting\, there will be a presentation of the call and you as an applicant will have the opportunity to ask questions about the call and the application process. \n\n\n\nregister here to receive zoom link\n\n\n\nApply in the call here\n\n\n\nThe mission of the Drug Discovery and Development Platform at SciLifeLab is to support researchers in developing new drugs\, transforming academic ideas into new treatments. To this end\, the DDD platform provides state-of-the-art drug discovery technologies to scientists across the country. Therapeutic oligonucleotides are a recent addition to the DDD platform’s capacity\, complementing the previous focus on small molecule and protein drugs. Oligonucleotide drugs have different modes of action\, and a potentially faster development compared to other drug types. Therapeutic oligonucleotide development is supported by the OligoNova Hub\, based in Gothenburg and part of SciLifeLab’s DDD platform. \n\n\n\nIn this call\, we are looking for project ideas for new therapeutic oligonucleotides that can be developed at DDD and OligoNova Hub. Approved project ideas will be developed in close collaboration between the academic laboratory and drug development experts at DDD and OligoNova Hub. The costs of the projects will mainly be covered by OligoNova\, but academic partners will be expected to contribute by paying for reagent costs. \n\n\n\nThe call is open for scientists with a doctoral degree at a Swedish university or higher institution. English should be used when filling out this application. You are responsible for ensuring that the application is complete. Incomplete applications will not be processed. Attach only material that we explicitly request. SciLifeLab DDD/OligoNova will not accept additional information after the closing date for applications\, except for information we ourselves explicitly request. Applications are reviewed by a review committee with international representation. \n\n\n\nCall Announcement FlyerDownload\n\n\n\nThe call is open March 28\, 2022 to May 13\, 2022.
URL:https://www.scilifelab.se/event/information-meeting-call-for-therapeutic-oligonucleotide-projects/
LOCATION:Online event via Zoom
CATEGORIES:Event
END:VEVENT
END:VCALENDAR